Detalhe da pesquisa
1.
Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
; 14(7)2022 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406454
2.
Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab®.
Onco Targets Ther
; 13: 5515-5527, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32606767
3.
UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells.
Oncoimmunology
; 9(1): 1743036, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32426176
4.
"UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells.
Sci Rep
; 10(1): 2141, 2020 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32034289
5.
An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells.
Sci Rep
; 9(1): 10547, 2019 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31332252
6.
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells.
Oncotarget
; 8(65): 108584-108603, 2017 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29312553